文献速递脑血管病

GRECOS项目:用基因预测卒中后血管复发风险

GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence After Stroke.
PubMed 文献 · Stroke · 2017-04-14

GRECOS项目在3个队列共4482例缺血性卒中或短暂性脑缺血发作患者中分析115个候选基因的256个多态性,发现MGP基因rs1800801与随访第一年新发缺血性卒中相关,并构建GRECOS评分可将患者从低风险1.9%分层至高风险12.6%。

要点

  • MGP基因rs1800801与随访第一年新发缺血性卒中相关(HR 1.33;P=9×10-03)。
  • GRECOS评分可预测新发缺血性卒中(P=3.2×10-09),风险分层从1.9%至12.6%。
  • GRECOS评分加入遗传风险因素后,预测优于既往Stroke Prognosis Instrument-II评分(P=0.03)。

核心结论

  • 遗传学可能有助于估计缺血性卒中后的血管复发风险。
  • MGP基因的遗传变异与西班牙人群的血管复发相关。

研究设计与样本

  • 分析115个候选基因的256个多态性,纳入3个队列共4482例缺血性卒中或短暂性脑缺血发作患者。
  • 发现队列为前瞻性招募的1494例患者,其中6.2%在随访第一年发生新发缺血性卒中。
  • 在2988例患者中使用SNPlex或HumanOmni1-Quad技术进行重复分析。
  • 采用Cox回归构建GRECOS评分,并用分类树方法生成风险分组。

主要发现

  • MGP基因rs1800801与随访第一年新发缺血性卒中相关(HR 1.33;P=9×10-03)。
  • GRECOS评分可预测新发缺血性卒中(P=3.2×10-09),并将患者从低复发风险1.9%分层至高危12.6%。
  • GRECOS评分加入遗传风险因素后,预测优于既往Stroke Prognosis Instrument-II评分(P=0.03)。

关键数值与推荐

  • MGP基因rs1800801与随访第一年新发缺血性卒中的风险比为1.33(P=9×10-03)。
  • GRECOS评分预测新发缺血性卒中的P值为3.2×10-09。
  • 风险分组从低风险1.9%至高危12.6%。
  • GRECOS评分加遗传风险因素对比Stroke Prognosis Instrument-II评分的P值为0.03。

临床怎么用

  • 可考虑用GRECOS评分结合遗传风险因素对缺血性卒中或短暂性脑缺血发作患者进行复发风险分层。
  • MGP基因rs1800801的关联在西班牙人群中被重复验证,在其他人群中的应用需谨慎。

局限性

  • 原文未报告GRECOS评分的具体变量构成与验证细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Vascular recurrence occurs in 11% of patients during the first year after ischemic stroke (IS) or transient ischemic attack. Clinical scores do not predict the whole vascular recurrence risk; therefore, we aimed to find genetic variants associated with recurrence that might improve the clinical predictive models in IS. METHODS: We analyzed 256 polymorphisms from 115 candidate genes in 3 patient cohorts comprising 4482 IS or transient ischemic attack patients. The discovery cohort was prospectively recruited and included 1494 patients, 6.2% of them developed a new IS during the first year of follow-up. Replication analysis was performed in 2988 patients using SNPlex or HumanOmni1-Quad technology. We generated a predictive model using Cox regression (GRECOS score [Genotyping Reurrence Risk of Stroke]) and generated risk groups using a classification tree method. RESULTS: The analyses revealed that rs1800801 in the MGP gene (hazard ratio, 1.33; P=9×10-03), a gene related to artery calcification, was associated with new IS during the first year of follow-up. This polymorphism was replicated in a Spanish cohort (n=1.305); however, it was not significantly associated in a North American cohort (n=1.683). The GRECOS score predicted new IS (P=3.2×10-09) and could classify patients, from low risk of stroke recurrence (1.9%) to high risk (12.6%). Moreover, the addition of genetic risk factors to the GRECOS score improves the prediction compared with previous Stroke Prognosis Instrument-II score (P=0.03). CONCLUSIONS: The use of genetics could be useful to estimate vascular recurrence risk after IS. Genetic variability in the MGP gene was associated with vascular recurrence in the Spanish population.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Fernández-Cadenas I, Mendióroz M, Giralt D, et al. GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence After Stroke. Stroke. 2017. PMID: 28411264. doi:10.1161/STROKEAHA.116.014322

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。